Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
September 15, 2021
Scientist.com Announces Acquisition of InsideScientific, a Life Science Webinar, Virtual Event and Content Creation Company
September 9, 2021
RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels
September 9, 2021
Pear and Thimble Point Announce Nominees to Board of Directors
September 9, 2021
VOR33 Granted U.S. FDA Fast Track Designation for AML
September 3, 2021
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
August 26, 2021
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
August 24, 2021
Nouscom Announces First Patient Dosed in a Phase 1B Trial with NOUS-PEV, a Novel Personalized Cancer Immunotherapy, in Advanced Melanoma or Lung Cancer
August 2, 2021
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 29, 2021
Rallybio Corporation Announces Pricing of Initial Public Offering
July 29, 2021
CinCor Pharma Appoints Marc de Garidel as Chief Executive Officer
« Previous Page
1
…
34
35
36
37
38
…
118
Next Page »